Drug Maker Named In Investor Suit Over I&I Drug Financial Success Estimates

(April 20, 2021, 9:06 AM EDT) -- NEWARK, N.J. — A biotechnology company and three of its former senior executives violated federal securities laws by issuing a series of misrepresentations regarding the expected financial windfall of two new...
To view the full article, register now.